Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Bell

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Medicine|November 1, 1981
Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literatureR L Ridolfi, W R Bell
Critical Reviews in Oncology/Hematology|January 1, 1984
The fibrinolytic system in manA P Reiner, W R Bell
Clinics in Chest Medicine|September 1, 1984
Treatment of pulmonary embolism and deep vein thrombosis with thrombolytic therapyG B Volgesang, W R Bell
Surgery|April 1, 1979
Low-dose heparin--concern and perspectivesW R Bell, G D Zuidema
The American Journal of Physiology|November 1, 1974
Fibrinogen-fibrin degradation products and fibrinolysis following exercise in humansJ E Karp, W R Bell
Medicine|May 1, 1991
Aspirin in the prevention of thrombosisJ A Lekstrom, W R Bell
The Journal of Laboratory and Clinical Medicine|May 1, 1979
Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and BC M Kessler, W R Bell
The New England Journal of Medicine|December 6, 1979
Current concepts: guidelines for the use of thrombolytic agentsW R Bell, A G Meek
Thrombosis Research|July 1, 1976
Methods for correcting inhibitory effects of fibrinogen degradation products in fibrinogen determinationsB M Alving, W R Bell
Comprehensive Therapy|November 1, 1981
Hemostatic disordersS J McPhee, W R Bell
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Medicine|November 1, 1981
Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literatureR L Ridolfi, W R Bell
Critical Reviews in Oncology/Hematology|January 1, 1984
The fibrinolytic system in manA P Reiner, W R Bell
Clinics in Chest Medicine|September 1, 1984
Treatment of pulmonary embolism and deep vein thrombosis with thrombolytic therapyG B Volgesang, W R Bell
Surgery|April 1, 1979
Low-dose heparin--concern and perspectivesW R Bell, G D Zuidema
The American Journal of Physiology|November 1, 1974
Fibrinogen-fibrin degradation products and fibrinolysis following exercise in humansJ E Karp, W R Bell
Medicine|May 1, 1991
Aspirin in the prevention of thrombosisJ A Lekstrom, W R Bell
The Journal of Laboratory and Clinical Medicine|May 1, 1979
Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and BC M Kessler, W R Bell
The New England Journal of Medicine|December 6, 1979
Current concepts: guidelines for the use of thrombolytic agentsW R Bell, A G Meek
Thrombosis Research|July 1, 1976
Methods for correcting inhibitory effects of fibrinogen degradation products in fibrinogen determinationsB M Alving, W R Bell
Comprehensive Therapy|November 1, 1981
Hemostatic disordersS J McPhee, W R Bell
Pageof 20